MedTrace Logo

CtDNA After Chemotherapy in Elderly Patients With Acute Leukemia

NCT04157569 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2020-02-25

No results posted yet for this study

Summary

This study will monitor CtDNA After Chemotherapy in Elderly Patients With AL

Conditions

Sponsors & Collaborators

  • Navy General Hospital, Beijing

    lead OTHER

Principal Investigators

  • Liren Qian, MD · Navy General Hospital, Beijing

Eligibility

Min Age
60 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-05
Primary Completion
2024-12-31
Completion
2029-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04157569 on ClinicalTrials.gov